IMMUNOCELLULAR THERAPEUTICS's ticker is IMUCWS and the CUSIP is 452536121. A total of 4 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $30,000 | +3.4% | 117,187 | -0.0% | 0.02% | -18.2% |
| Q1 2018 | $29,000 | -21.6% | 117,188 | 0.0% | 0.02% | -12.0% |
| Q4 2017 | $37,000 | -15.9% | 117,188 | 0.0% | 0.02% | +257.1% |
| Q3 2017 | $44,000 | -56.0% | 117,188 | 0.0% | 0.01% | -78.1% |
| Q2 2017 | $100,000 | -73.2% | 117,188 | 0.0% | 0.03% | -79.4% |
| Q1 2017 | $373,000 | +55.4% | 117,188 | 0.0% | 0.16% | +106.7% |
| Q4 2016 | $240,000 | – | 117,188 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 117,188 | $44,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 420,103 | $8,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 93,737 | $2,000 | 0.00% |
| UBS Group AG | 2,858 | $0 | 0.00% |